Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
AMGN > SEC Filings for AMGN > Form 8-K on 19-Nov-2013All Recent SEC Filings

Show all filings for AMGEN INC

Form 8-K for AMGEN INC


Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure.

On November 19, 2013, Onyx Pharmaceuticals, Inc. ("Onyx"), a subsidiary of Amgen Inc., is issuing a notice of redemption to holders of Onyx's outstanding 4.00% Convertible Senior Notes due 2016 (CUSIP Number 683399AB5) (the "Notes") announcing its intention to redeem all outstanding Notes in full on December 24, 2013 in accordance with the terms of the indenture governing the Notes, at a redemption price of $1,115.99 per $1,000 principal amount of Notes redeemed (which includes a make-whole premium of $101.66 per $1,000 principal amount of Notes). The remaining outstanding aggregate principal amount of the Notes as of November 15, 2013 was $35,000.00.

The information furnished in this report shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.


  Add AMGN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for AMGN - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.